CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.09
+3.96%Oct 29, 2026, 00:31 UTC
ClearPoint Neuro reported a quarterly loss of $0.24 per share, compared with a loss of $0.21 per share a year earlier.
Source:Oct 28, 2026, 21:02 UTC
ClearPoint Neuro reported third-quarter 2026 revenue of $12.075 million, up 36% year over year, and a net loss of $7.46 million.
Oct 14, 2026, 20:05 UTC
ClearPoint Neuro announced that it will release its third-quarter 2026 financial results after the market close on October 28, 2026.
Source:Sep 24, 2026, 06:01 UTC
Julier Medical appointed Will Martin as President and Chief Executive Officer.
Source:Aug 5, 2026, 07:09 UTC
ClearPoint Neuro reported second-quarter 2026 revenue of $10.9 million, up 18% from $9.2 million in the prior-year period.
Source:Aug 3, 2026, 20:05 UTC
ClearPoint Neuro reported second quarter 2026 revenue of $10.9 million, an 18% increase year-over-year, with biologics and drug delivery revenue declining 15% due to fewer products shipped to biopharma customers for new trial initiations.